Form 4: Astrana Health Director David Schmidt Reports Stock Transactions

Director David Schmidt reports exercising stock options and subsequent sale of shares in Astrana Health, Inc.

Summary

• On August 14, 2024, David Schmidt, a director of Astrana Health, Inc., exercised stock options to acquire 11,000 shares at $15.35 and 3,409 shares at $18.41.
• On August 16, 2024, Schmidt disposed of 14,409 shares at $49.76.
• Following these transactions, Schmidt beneficially owns 9,314 shares of common stock, including 5,750 shares of restricted stock vesting on December 9, 2024, and 3,564 shares vesting on August 13, 2025, or the date of the Issuer's 2025 annual meeting of stockholders.

Sentiment

Score: 5

Explanation: This is a routine disclosure of insider transactions. The sentiment is neutral as it simply reflects the director's trading activity.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and potential future performance of the company.

Comparison to Industry Standards

• Form 4 filings are a standard practice across all publicly traded companies in the US, ensuring transparency in insider trading activities.
• Companies like UnitedHealth Group (UNH) and CVS Health (CVS) also have similar insider transaction disclosures, which are routinely monitored by investors.

Stakeholder Impact

• Shareholders may interpret the director's sale of shares as a signal, although it could be for personal financial reasons and not necessarily indicative of the company's future performance.

Key Dates